Skip to content

Public FDA record

Z-1887-2016: HeartWare Ventricular Assist System: HeartWare Battery, Lithium Ion, 14.8 V, Rx only. Catalog 1650 (US)

Recall record Z-1887-2016 for Heartware, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1887-2016
Company in FDA record
Heartware, Inc.
FDA classification date
Jul 8, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Heartware Ventricular Assist System Battery Cell experiencing premature depletion.

Source facts

Action
The firm, HeartWare, sent an "URGENT MEDICAL DEVICE RECALL" letter dated January 7, 2016, to all their consignees informing them that of the HeartWare HVAD Battery recall (device exchange). The letter described the product, problem and actions to be taken. The customers were instructed to: 1. Promptly complete the attached Acknowledgment Form and return it to HeartWare no later than 30 days from the date of this letter via email to HeartWare7786@stericycle.com or provide verbal Acknowledgement by calling Customer Service line , 1(844)491-7871; or fax to +1 (844)721-3044.. 2. Immediately identify and quarantine affected batteries in hospital inventory, and apply a RECALLED PRODUCT DO NOT USE sticker (provided with this notice) as illustrated below. Replace quarantined inventory AC Adapters and batteries by requesting a Return Goods Authorization (RGA) through a qualified representative or directly through HeartWare Customer Service (via telephone 1-877-367-4823 or email cs@heartware.com). A qualified representative will update the Controller software for affected Controller units in inventory. 3. Identify, collect and quarantine affected product in patient possession. Arrange for current patients to bring their Batteries to a clinic appointment as soon as possible, (at least within the next three months), with urgency dependent upon individual patient circumstances. During their regularly scheduled appointment, a qualified representative will assist with quarantining and replacing affected product. Apply a RECALLED PRODUCT DO NOT USE sticker as illustrated on affected batteries. Replace affected patient product using hospital inventory, and replace consumed hospital inventory by requesting an RGA as described above. 4. Return affected product to HeartWare. Your HeartWare representative will assist you with returning affected product to HeartWare. 5. Complete and return the attached Completion Form no later than 6 months from the date of this let
Initiated
2016-01-07
Root cause
Software design
Terminated
2020-03-27
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MI, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and Washington D.C.
Recall number
Z-1887-2016
Recall status
Terminated
CDRH record ID
144646
FDA classified
2016-07-08
Recall event number
73636

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗